| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/10/2004 | WO2003068967A3 Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants |
| 09/10/2004 | WO2003045230A3 Novel compositions and methods for cancer |
| 09/10/2004 | WO2003038061A3 Ehrlichia disulfide bond formation proteins and uses thereof |
| 09/10/2004 | WO2003028539A3 Materials and methods for the diagnosis of pediatric tumors |
| 09/10/2004 | WO2003016330A3 Molecular linkers suitable for crystallization and structural analysis of molecules of interest, method of using same, and methods of purifying g protein-coupled receptors |
| 09/10/2004 | WO2003006680A3 Omi and domains thereof that disrupt iap-caspase interaction |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002094999A3 Polynucleotide encoding a novel trp channel family member, trp-plik2, and splice variants thereof |
| 09/10/2004 | WO2002092840A3 Agents that regulate apoptosis |
| 09/10/2004 | CA2788505A1 Polymer-factor viii moiety conjugates |
| 09/10/2004 | CA2519193A1 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | CA2517285A1 Transcriptional factor inducing apoptosis in cancer cell |
| 09/10/2004 | CA2517258A1 Recombinant measles virus comprising dengue or west nile virus polynucleotides, and their use in vaccinal and therapeutic applications |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2517062A1 Vaccines derived from epithelial cell mucin muc-1 |
| 09/10/2004 | CA2517052A1 Polyvalent immunogen |
| 09/10/2004 | CA2516834A1 Polypeptides and methods for making the same |
| 09/10/2004 | CA2516727A1 Hypoxia inducible vegf plasmid for ischemic disease |
| 09/10/2004 | CA2516651A1 Methods of screening for trpm5 modulators |
| 09/10/2004 | CA2516645A1 Abiotic stress responsive plant transcription factor polynucleotides and polypeptides and use thereof for generating transgenic plants |
| 09/10/2004 | CA2516640A1 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis |
| 09/10/2004 | CA2516619A1 Glutamate transport modulatory compounds and methods |
| 09/10/2004 | CA2516552A1 Polyethylene glycol modified interferon compositions and methods of use thereof |
| 09/10/2004 | CA2516518A1 Antibody purification by protein a and ion exchange chromatography |
| 09/10/2004 | CA2515916A1 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors |
| 09/10/2004 | CA2515798A1 Peptide inhibitors of thrombin as potent anticoagulants |
| 09/10/2004 | CA2514329A1 Methods for the treatment of renal cell carcinoma |
| 09/10/2004 | CA2513836A1 Hypoallergenic der p1 and der p3 proteins from dermatographoides pteronyssinus |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/10/2004 | CA2422906A1 Fish and seal collagens as cell matrices for cell culture |
| 09/09/2004 | US20040177404 Nucleotide sequences of 2S albumin gene and its promoter from grape and uses thereof |
| 09/09/2004 | US20040177401 Genes encoding sulfate assimilation proteins |
| 09/09/2004 | US20040177393 Genetically engineered rodent which expresses glycoprotein 120 binding ligand for diagnosis, prevention, detection and treatment of lentiviral infection; viricides |
| 09/09/2004 | US20040177392 Crustaceans as production systems for therapeutic proteins |
| 09/09/2004 | US20040177391 Cell signaling associated polypeptides for identifying modulators of immune cell interactions and mamalian cellular response; tissue engineering |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040177387 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders |
| 09/09/2004 | US20040176912 Methods for designing specific inhibitors for Pin1 proline isomerase and Pin1-related molecules |
| 09/09/2004 | US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 09/09/2004 | US20040176582 Expression vector comprising osteocalcin promoter and nucleotide sequence coding bone morphogenic protein for treatment and prevention of osteoporosis |
| 09/09/2004 | US20040176579 One-step reduction and alkylation of proteins |
| 09/09/2004 | US20040176578 Amino acid sequences capable of associating with fluorophore dyes for use as diagnostic tools in vitro and invivo detection and assay systems |
| 09/09/2004 | US20040176576 Antibodies against cancer |
| 09/09/2004 | US20040176575 Compounds comprising modified secondary ligand binding site for treatment and prevention of infections, diabetes, emphysema, viral, endocrine and cell proliferative disorders |
| 09/09/2004 | US20040176574 Comprises organic cation transporter polypeptide for use in diagnostic, prevention and treatment of metabolic and cell proliferative disorders |
| 09/09/2004 | US20040176573 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
| 09/09/2004 | US20040176572 Nucleotide sequences coding nervous system polypeptide for use in diagnosis, prevention and treatment of neurodegenerative and psychological disorders |
| 09/09/2004 | US20040176571 Genetically modified cholera toxin (CT-CRM) comprising reduced toxicity and enhanced immunological response for use in preparation of vaccines against parasitic infection |
| 09/09/2004 | US20040176569 Regioselective liquid phase pegylation |
| 09/09/2004 | US20040176568 Nucleic acids encoding modified parathyroid hormone |
| 09/09/2004 | US20040176567 Bioactive peptides comprising enhanced solubility and reduced aggregatory characteristics for use in diagnosis, prevention and treatment of hypercalaemia, osteoporosis and paget's disease |
| 09/09/2004 | US20040176314 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 09/09/2004 | US20040176301 p21 peptides |
| 09/09/2004 | US20040176296 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |
| 09/09/2004 | US20040176293 Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof |
| 09/09/2004 | US20040176291 Methods and compositions for soluble CPG15 |
| 09/09/2004 | US20040176287 Employing such as follistatin to increase differentiation of stromal stem cells, myoblast and undifferentiated stromal cells to osteoblast cells |
| 09/09/2004 | US20040176285 Tip39 polypeptides |
| 09/09/2004 | US20040176283 Methods and compositions for the design of synthetic vaccines |
| 09/09/2004 | US20040176279 Flint glycoforms |
| 09/09/2004 | US20040176278 B-superfamily conotoxins |
| 09/09/2004 | US20040175831 Strains "fil", stress-resistant under fermentation and/or growth conditions |
| 09/09/2004 | US20040175829 Nucleocapsid-independent specific viral RNA packaging and uses thereof |
| 09/09/2004 | US20040175824 Fc fusion proteins of human erythropoietin with high biological activities |
| 09/09/2004 | US20040175813 can be delivered separately or in combination with apoptotic inducing agents via aerosol liposome/transfection/infection methods to treat cellular proliferative diseases and disorders in humans and animals |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175802 Neutrokine-alpha and Neutrokine-alpha splice variant |
| 09/09/2004 | US20040175801 for drug screening/detecting/treating immune system-related disorders (cancer); genetic engineering |
| 09/09/2004 | US20040175800 for genetically engineered proteins with increase in solubility and in vivo stability and a decrease in immunogenicity |
| 09/09/2004 | US20040175797 Alternatively spliced isoforms of inhibitor of kappa-B kinase gamma (IKBKG) |
| 09/09/2004 | US20040175796 Novel human G-protein coupled receptor |
| 09/09/2004 | US20040175795 Glial derived neurotrophic factor |
| 09/09/2004 | US20040175794 for angiogenic diseases (cancer, cancer metasis, chronic inflammatory disorders, rheumatoid arthritis, atherosclerosis, macular degeneration, diabetic retinopathy), restenosis, Alzheimer's disease and tissue remodeling; genetic engineering |
| 09/09/2004 | US20040175793 Cell lines that stably or transiently express a functional umami (T1R1/T1R3) taste receptor |
| 09/09/2004 | US20040175792 co-expression results in a hetero-oligomeric taste receptor that responds to sweet taste stimuli; high throughput assay; solid phase synthesis |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175790 for drug screening/diagnostics for detecting and treating immune system-related disorders (cancer); genetic engineering |
| 09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
| 09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175772 for drug screening cancer drugs and tumor activators/suppressors; fluorescence resonance energy transfer; genetic engineering |
| 09/09/2004 | US20040175766 Human pyrimidine receptor |
| 09/09/2004 | US20040175763 Branched multiple antigenic peptide for accurate diagnosis of inflammatory bowel disorders |
| 09/09/2004 | US20040175761 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof |
| 09/09/2004 | US20040175748 Using alterations in cyclin dependent kinase activity to identify modulators which inhibit or potentiate cellular senescence; antiaging/anticancer agents; enzyme inhibitors |
| 09/09/2004 | US20040175745 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/09/2004 | US20040175740 Using proopiomelanocortin animal mutant to identify modulators of weight and pancreatic disorders |
| 09/09/2004 | US20040175739 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/09/2004 | US20040175738 Novel osteopontin derived chemotactic peptides and methods of use |
| 09/09/2004 | US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
| 09/09/2004 | US20040175721 Antisense nucleotide sequences for use in reducing cell division associated with cell proliferative, skin and autoimmune disorders; RNA interference and microtuble formation |
| 09/09/2004 | US20040175720 NIF-1 is a novel co-transducer that interacts with and regulates the activity of the nuclear hormone receptor co-activator, NRC |
| 09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
| 09/09/2004 | US20040175705 Expression vector for transformation and expression of heterologous polypeptides in methylococcal/methanotrophic bacteria; bioreactors |
| 09/09/2004 | US20040175700 Using phenotypic, genotypic, physiological and morphogenic variation profiles to diagnose and prognose genetic disorders; genomics |
| 09/09/2004 | US20040175699 Nucleotide sequences coding myosin binding protein-C 3-cardiac (MYBPC) regulatory sequence for use as gene therapeutic tools in expressing proteins for treating cardiomyopathies, myocardial infarction and cardiac rhythm disorders |
| 09/09/2004 | US20040175698 Regulation of human latrophilin-like g protein-coupled receptor |
| 09/09/2004 | US20040175694 Tobamovirus vector for transformation and propagation of protective antibodies in plants; genetic vaccine for preventing parasitic infections |
| 09/09/2004 | US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |